Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2022-08-16 00:00:00 ET · period of report 2022-08-12 · accession 0001415889-22-008738 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-08-16 | 2022-08-12+ | ANIP | Marken James G. | SVP OPS, PROD DEV | S - Sale | $37.25 | -18.1K | 122.8K | -13% | -$673.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-15 | S | D | 5,172 | $37.79 | 117,642 | D | — | — | (F2) The shares were sold in multiple trades at prices ranging from $37.70 to $38.00. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2022-08-12 | S | D | 12,894 | $37.04 | 122,814 | D | — | — | (F1) The shares were sold in multiple trades at prices ranging from $37.01 to $37.295. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |